表紙
市場調査レポート

世界の原薬(API)市場

Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

発行 GBI Research 商品コード 254559
出版日 ページ情報 英文 221 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
世界の原薬(API)市場 Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
出版日: 2012年11月09日 ページ情報: 英文 221 Pages
概要

世界の原薬(API)市場は、北米が独占しており、2011年の世界のAPI収益の35.1%を占めております。アジア太平洋地域は急速に成長しており、2011年の収益シェアは29.7%で北米に続く2番目の地域となっております。

当レポートでは、世界の原薬(API)市場について調査分析を行い、市場に影響を及ぼすような経済動向および市場動向の分析および市場見通し、製品分析、成長促進因子、成長抑制因子などについて考察してまとめ、概略下記の構成で取り上げております。

第1章 目次

第2章 イントロダクション

第3章 世界の原薬市場

  • 世界の原薬市場の概要
  • 世界の原薬市場の促進因子
  • 世界の原薬市場の抑制因子
  • 世界の原薬市場の収益分析と見通し
  • 世界のバイオテクノロジー市場分析
  • 世界のバイオテクノロジー市場の収益分析:顧客ベース別
  • 世界の医薬品受託製造機関

第4章 北米の原薬市場

  • 北米の原薬市場の概要
  • 北米の原薬市場の促進因子
  • 北米の原薬市場の抑制因子
  • 北米の原薬市場の収益分析と見通し
  • 北米の原薬市場の収益シェア分析:製品別
  • 北米の合成品市場分析
  • 北米のバイオテクノロジー市場分析
  • 北米の原薬市場の収益シェア分析:治療への応用別
  • 米国の原薬市場
  • カナダの原薬市場

第5章 アジア太平洋地域の原薬市場

  • アジア太平洋地域の原薬市場の概要
  • アジア太平洋地域の原薬市場の促進因子
  • アジア太平洋地域の原薬市場の抑制因子
  • アジア太平洋地域の原薬市場の収益と見通し
  • アジア太平洋地域の原薬市場の収益シェア分析:製品別
  • アジア太平洋地域の合成品市場
  • アジア太平洋地域のバイオテクノロジー市場
  • アジア太平洋地域の原薬市場シェア分析:治療への応用別
  • 日本の原薬市場
  • 中国の原薬市場
  • 韓国の原薬市場
  • インドの原薬市場

第6章 欧州の原薬市場

  • 欧州の原薬市場の概要
  • 欧州の原薬市場の促進因子
  • 欧州の原薬市場の抑制因子
  • 欧州の原薬市場の収益分析と見通し
  • 欧州の原薬市場の収益シェア分析:製品別
  • 欧州の合成品市場分析
  • 欧州のバイオテクノロジー市場分析
  • 欧州の原薬市場の収益シェア分析:治療への応用別
  • ドイツの原薬市場
  • フランスの原薬市場
  • イタリアの原薬市場
  • 英国の原薬市場
  • スペインの原薬市場

第7章 付録

図表

目次
Product Code: GBICH0073MR

Summary

GBI Research's report, "Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand" provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations' (CMO) growth in the region, and their influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The global APIs market was dominated by North America, which generated 35.1% of global API revenues in 2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of 29.7% in 2011.

The global APIs market revenues reached $108,613m in 2011. In the product-based segments, the synthetic market dominated the market with 82.7% of global APIs revenues.

However, increasing acceptance and increasing penetration are boosting the biopharmaceuticals drug market in both developed and developing economies.

Scope

  • Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.
  • API markets in the regions of North America, Asia-Pacific and Europe, along with key countries such as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK and Spain.
  • API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology globally.
  • Drivers and restraints for the global APIs market.
  • Detailed historical, forecast trend and share analysis of API revenues based on product types (synthetic and biotechnology APIs) at the global, regional and key country levels.
  • Detailed historical and forecast trends and share analysis for API revenues based on the customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) at the global, regional and key country levels.
  • Analysis of API revenues based on therapeutic categories at a global and regional level.

Reasons to buy

  • Develop business strategies with the help with specific insights in the global API market.
  • Identify opportunities and challenges in the global API market.
  • Invest in the growing segments of the APIs market.
  • Increase future revenue and profitability with the help of insights into the future opportunities and critical success factors in the global APIs market.
  • Benchmark your operations and strategies against the major players in the global APIs market.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

3. Global Active Pharmaceutical Ingredients Market

  • 3.1. Global API Market Overview
  • 3.2. Global API Market Drivers
    • 3.2.1. Patent Expiries to Change the Dynamics of the Global API Market
    • 3.2.2. Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for Biomedical Research Set to Boost API Revenues
    • 3.2.3. Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth
    • 3.2.4. Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global Pharmaceutical and API Markets
    • 3.2.5. Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in Underpenetrated Markets
  • 3.3. Global API Market Restraints
    • 3.3.1. Economic Recession to Restrict Investment in the Pharmaceutical Industry
    • 3.3.2. Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth Potential
    • 3.3.3. Increasing Patent Expiries to Impede Growth of the Global API Market
    • 3.3.4. Regulatory Changes to Delay the Launch of New Drugs
  • 3.4. Global API Market Revenue Analysis and Forecast to 2017
    • 3.4.1. Global API Market Revenue Share by Product Type
    • 3.4.2. Global Synthetic Market Revenue Analysis and Forecast to 2017
    • 3.4.3. Global Synthetic Market Revenue Share Analysis by Customer Base
    • 3.4.4. Global Synthetic Market Revenue Analysis and Forecast to 2017
  • 3.5. Global Biotech Market Analysis
    • 3.5.1. Global Biotech Market Revenue Analysis and Forecast to 2017
  • 3.6. Global Biotech Market Revenue Analysis by Customer Base
    • 3.6.1. Global Biotech Market Revenue Share Analysis by Customer Base
    • 3.6.2. Global Biotech Market Revenue Analysis and Forecast to 2017
  • 3.7. Global Contract Manufacturing Organizations
    • 3.7.1. Global CMO Outsourcing Process
    • 3.7.2. Global CMO Market Drivers
    • 3.7.3. Global CMO Market Outsourcing Benefits
    • 3.7.4. Global CMO Market Revenues and Forecast to 2017

4. North America Active Pharmaceutical Ingredients Market

  • 4.1. North America API Market Overview
  • 4.2. North America API Market Drivers
    • 4.2.1. Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America
    • 4.2.2. Generic Sector Supports the Growth of the North American API Market
    • 4.2.3. Increasing Focus on Biological Drugs to Support API Market Revenue Growth
  • 4.3. North American API Market Restraints
    • 4.3.1. Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth
    • 4.3.2. High Cost of New Drug Development Hampers Innovation
    • 4.3.3. Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America
  • 4.4. North America API Market Revenue Analysis and Forecast to 2017
  • 4.5. North America API Market Revenue Share Analysis by Product Type
  • 4.6. North America Synthetic Market Analysis
    • 4.6.1. North America Synthetic Market Revenue Analysis and Forecast to 2017
    • 4.6.2. North America Synthetic Market Revenue Share Analysis by Customer Base
    • 4.6.3. North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017
  • 4.7. North America Biotech Market Analysis
    • 4.7.1. North America Biotech Market Revenue Analysis and Forecast to 2017
    • 4.7.2. North America Biotech Market Revenue Share Analysis by Customer Base
    • 4.7.3. North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017
  • 4.8. North America API Market Revenue Share Analysis by Therapeutic Applications
  • 4.9. The US Active Pharmaceutical Ingredients Market
    • 4.9.1. The US API Market Overview
    • 4.9.2. The US API Market Revenue by Product Type and Forecast to 2017
    • 4.9.3. The US API Market Revenue Share Analysis by Product Type and Forecast to 2017
    • 4.9.4. The US API Market by Customer Base
  • 4.10. Canada Active Pharmaceutical Ingredients Market
    • 4.10.1. Canada API Market Overview
    • 4.10.2. Canada API Market Revenue Analysis by Product Type and Forecast to 2017
    • 4.10.3. Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017
    • 4.10.4. Canada API Market by Customer Base

5. Asia-Pacific Active Pharmaceutical Ingredients Market

  • 5.1. Asia-Pacific API Market Overview
  • 5.2. Asia-Pacific APIs Market Drivers
    • 5.2.1. Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract API Manufacture
    • 5.2.2. Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical Industry Growth
    • 5.2.3. Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market Growth
    • 5.2.4. Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs
    • 5.2.5. Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets
  • 5.3. Asia-Pacific API Market Restraints
    • 5.3.1. Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market
    • 5.3.2. Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market
    • 5.3.3. Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential
    • 5.3.4. Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region
  • 5.4. Asia-Pacific API Market Revenue and Forecasts to 2017
  • 5.5. Asia-Pacific Revenue Share Analysis by Product Type
  • 5.6. Asia-Pacific Synthetic Market
    • 5.6.1. Asia-Pacific Synthetic Market Revenues and Forecast to 2017
    • 5.6.2. Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base
    • 5.6.3. Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017
  • 5.7. Asia-Pacific Biotech Market
    • 5.7.1. Asia-Pacific Biotech Market Revenues and Forecasts to 2017
    • 5.7.2. Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base
    • 5.7.3. Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017
  • 5.8. Asia-Pacific API Market Share Analysis by Therapeutic Applications
  • 5.9. Japan Active Pharmaceutical Ingredients Market
    • 5.9.1. Japan API Market Overview
    • 5.9.2. Japan API Market Revenues and Forecasts to 2017
    • 5.9.3. Japan API Market Revenue Share Analysis by Product Type
    • 5.9.4. Japan API Market by Customer Base
  • 5.10. China Active Pharmaceutical Ingredients Market
    • 5.10.1. China API Market Overview
    • 5.10.2. China API Market Revenues by Product Type and Forecasts to 2017
    • 5.10.3. China API Market Revenue Share Analysis by Product Types
    • 5.10.4. China API Market by Customer Base
  • 5.11. South Korea Active Pharmaceutical Ingredients Market
    • 5.11.1. South Korea API Market Overview
    • 5.11.2. South Korea APIs Market Revenue and Forecasts to 2017
    • 5.11.3. South Korea API Market Revenue Share Analysis by Product Type
    • 5.11.4. South Korea API Market by Customer Base
  • 5.12. India Active Pharmaceutical Ingredients Market
    • 5.12.1. India API Market Overview
    • 5.12.2. India API Market Revenue and Forecasts to 2017
    • 5.12.3. India API Market Revenue Share Analysis by Product Types
    • 5.12.4. India API Market by Customer Base

6. Europe Active Pharmaceutical Ingredients Market

  • 6.1. Europe API Market Overview
  • 6.2. Europe API Market Drivers
    • 6.2.1. Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue Growth in Europe
    • 6.2.2. Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for the European API Market
    • 6.2.3. Biopharmaceutical Therapies to Support API Market Growth in Europe
    • 6.2.4. European Regulatory Framework to Facilitate Development of Biosimilars
    • 6.2.5. Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe
  • 6.3. Europe API Market Restraints
    • 6.3.1. Increased Consumption of Generics to Limit the Premium Earned from Branded Products
    • 6.3.2. Increasing Patent Expiries to Hamper the Growth of the European API Market
    • 6.3.3. Price Cuts to Restrict Revenue Growth for the European API Market
  • 6.4. Europe API Market Revenue Analysis and Forecast to 2017
  • 6.5. Europe API Market Revenue Share Analysis by Product Type
  • 6.6. Europe Synthetic Market Analysis
    • 6.6.1. Europe Synthetic Market Revenue Analysis and Forecast to 2017
    • 6.6.2. European Synthetic Market Revenue Share Analysis by Customer Base
    • 6.6.3. Europe Synthetic Market Revenue by Customer Base and Forecast to 2017
  • 6.7. Europe Biotech Market Analysis
    • 6.7.1. Europe Biotech Market Revenue Analysis and Forecast to 2017
    • 6.7.2. Europe Biotech Market Revenue Share Analysis by Customer Base
    • 6.7.3. Europe Biotech Market Revenues by Customer Base and Forecast to 2017
  • 6.8. Europe API Market Revenue Share Analysis by Therapeutic Applications
  • 6.9. Germany Active Pharmaceutical Ingredients Market
    • 6.9.1. Germany API Market Overview
    • 6.9.2. Germany API Market Revenue Analysis by Product Type and Forecast to 2017
    • 6.9.3. Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017
    • 6.9.4. Germany API Market by Customer Base
  • 6.10. France Active Pharmaceutical Ingredients Market
    • 6.10.1. France API Market Overview
    • 6.10.2. France API Market Revenue Analysis by Product Type and Forecast to 2017
    • 6.10.3. France API Revenue Share Analysis by Product Type and Forecast to 2017
    • 6.10.4. France API Market by Customer Base
  • 6.11. Italy Active Pharmaceutical Ingredients Market
    • 6.11.1. Italy API Market Overview
    • 6.11.2. Italy API Market Revenue Analysis by Product Type and Forecast to 2017
    • 6.11.3. Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017
    • 6.11.4. Italy API Market by Customer Base
  • 6.12. The UK Active Pharmaceutical Ingredients Market
    • 6.12.1. The UK API Market Overview
    • 6.12.2. The UK API Market Revenue Analysis by Product Type and Forecast to 2017
    • 6.12.3. The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017
    • 6.12.4. The UK API Market by Customer Base
  • 6.13. Spain Active Pharmaceutical Ingredients Market
    • 6.13.1. Spain API Market Overview
    • 6.13.2. Spain API Market Revenue Analysis by Product Type and Forecast to 2017
    • 6.13.3. Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017
    • 6.13.4. Spain API Market by Customer Base

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Market Definitions
  • 7.4. Methodology
    • 7.4.1. Coverage
    • 7.4.2. Secondary Research
    • 7.4.3. Primary Research
    • 7.4.4. Expert Panel Validation
  • 7.5. Contact Us
  • 7.6. Disclaimer

List of Tables

  • Table 1: API Market, Global, Total Revenue Analysis, $m, 2005-2017
  • Table 2: API Market, Global, Revenue Share by Product Types, %, 2011
  • Table 3: Synthetic Market, Global, Revenue Analysis, $m, 2005-2017
  • Table 4: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2011
  • Table 5: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2005-2017
  • Table 6: Synthetic Market, Global, Revenue Share by Customer Base, %, 2011
  • Table 7: Synthetic Market, Global, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 8: Biotech Market, Global, Revenue Analysis, $m, 2005-2017
  • Table 9: Biotech Market, Global, Revenue Share by Region, %, 2011
  • Table 10: Biotech Market, Global, Revenue Share Analysis by Region, %, 2005-2017
  • Table 11: Biotech Market, Global, Revenue Share Analysis by Customer Base, %, 2011
  • Table 12: Biotech Market, Global, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 13: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011
  • Table 14: CMO Market, Global, Market Revenues, $m, 2005-2017
  • Table 15: API Market, North America, Major Drugs to Lose Patent Protection, 2012-2016
  • Table 16: API Market, North America, Revenue Analysis by Product Type, $m, 2005-2017
  • Table 17: API Market, North America, Revenue Share by Product Type, %, 2005-2017
  • Table 18: Synthetic Market, North America, Revenue Analysis, $m, 2005-2017
  • Table 19: Synthetic Market, North America, Revenue Share Analysis by Countries, $m and %, 2011
  • Table 20: Synthetic Market, North America, Revenue Share Trend, %, 2005-2017
  • Table 21: Synthetic Market, North America, Revenue Share by Customer Base, (%), 2011
  • Table 22: Synthetic Market, North America, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 23: Biotech Market, North America, Revenue Analysis, $m, 2005-2017
  • Table 24: Biotech Market, North America, Revenue Share by Countries, $m and %, 2011
  • Table 25: Biotech Market, North America, Revenue Share Trend, %, 2005-2017
  • Table 26: Biotech Market, North America, Revenue Share Analysis by Customer Base, %, 2011
  • Table 27: Biotech Market, North America, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 28: API Market, North America, Revenue Split by Therapeutic Applications, %, 2011-2017
  • Table 29: API Market, The US, Revenue Analysis by Product Type, $m, 2005-2017
  • Table 30: API Market, The US, Revenue Share Analysis by Product Type, %, 2005-2017
  • Table 31: Synthetic Market, The US, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 32: Synthetic Market, The US, Revenue Share by Customer Base, %, 2005-2017
  • Table 33: Biotech Market, The US, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 34: Biotech Market, The US, Revenue Share by Customer Base, %, 2005-2017
  • Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005-2017
  • Table 36: API Market, Canada, Revenue Share by Product Type, %, 2005-2017
  • Table 37: Synthetic Market, Canada, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 38: Synthetic Market, Canada, Revenue Share by Customer Base, %, 2005-2017
  • Table 39: Biotech Market, Canada, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 40: Biotech Market, Canada, Revenue Share by Customer Base, %, 2005-2017
  • Table 41: API Market, Asia-Pacific, Market Revenues, $m, 2005-2017
  • Table 42: API Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011
  • Table 43: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005-2017
  • Table 44: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
  • Table 45: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries, $m, 2005-2017
  • Table 46: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011
  • Table 47: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005-2017
  • Table 48: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005-2017
  • Table 49: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
  • Table 50: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017
  • Table 51: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011
  • Table 52: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005-2017
  • Table 53: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011-2017
  • Table 54: API Market, Japan, Market Revenues by Product Types, $m, 2005-2017
  • Table 55: API Market, Japan, Revenue Share Analysis by Product Types, %, 2005-2017
  • Table 56: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005-2017
  • Table 57: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005-2017
  • Table 58: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005-2017
  • Table 59: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005-2017
  • Table 60: API Market, China, Market Revenues by Product Type, $m, 2005-2017
  • Table 61: API Market, China, Revenue Share Analysis by Product Type, %, 2005-2017
  • Table 62: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005-2017
  • Table 63: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017
  • Table 64: Biotech Market, China, Market Revenues by Customer Base, $m, 2005-2017
  • Table 65: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017
  • Table 66: API Market, South Korea, Market Revenues by Product Types, $m, 2005-2017
  • Table 67: API Market, South Korea, Revenue Share Analysis by Product Types, %, 2005-2017
  • Table 68: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017
  • Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005-2017
  • Table 70: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017
  • Table 71: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005-2017
  • Table 72: API Market, India, Market Revenues by Product Types, $m, 2005-2017
  • Table 73: API Market, India, Revenue Share Analysis by Product Types, %, 2005-2017
  • Table 74: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005-2017
  • Table 75: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005-2017
  • Table 76: Biotech Market, India, Market Revenues by Customer Base, $m, 2005-2017
  • Table 77: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005-2017
  • Table 78: Pharmaceutical Market, Leading Five European Countries, Pricing and Reimbursement Mechanism, 2011
  • Table 79: API Market, Europe, Total Revenue Analysis, $m, 2005-2017
  • Table 80: API Market, Europe, Revenue Share by Product Types, %, 2011
  • Table 81: Synthetic Market, Europe, Revenue Analysis, $m, 2005-2017
  • Table 82: Synthetic Market, Europe, Revenue Share Analysis by Countries, %, 2011
  • Table 83: Synthetic Market, Europe, Revenue Share Trend, %, 2005-2017
  • Table 84: Synthetic Market, Europe, Revenue Share by Customer Base, %, 2011
  • Table 85: Synthetic Market, Europe, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 86: Biotech Market, Europe, Revenue Analysis, $m, 2005-2017
  • Table 87: Biotech Market, Europe, Revenue Share by Countries, %, 2011
  • Table 88: Biotech Market, Europe, Revenue Share Trend, %, 2005-2017
  • Table 89: Biotech Market, Europe, Revenue Share Analysis by Customer Base, %, 2011
  • Table 90: Biotech Market, Europe, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 91: API Market, Europe, Revenue Split by Therapeutic Applications, %, 2011-2017
  • Table 92: API Market, Germany, Revenue Analysis by Product Types, $m, 2005-2017
  • Table 93: API Market, Germany, Revenue Share by Product Type, %, 2005-2017
  • Table 94: Synthetic Market, Germany, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 95: Synthetic Market, Germany, Revenue Share by Customer Base, %, 2005-2017
  • Table 96: Biotech Market, Germany, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 97: Biotech Market, Germany, Revenue Share by Customer Base, %, 2005-2017
  • Table 98: API Market, France, Revenue Analysis by Product Types, $m, 2005-2017
  • Table 99: API Market, France, Revenue Share by Product Type, %, 2005-2017
  • Table 100:Synthetic Market, France, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 101:Synthetic Market, France, Revenue Share by Customer Base, %, 2005-2017
  • Table 102:Biotech Market, France, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 103:Biotech Market, France, Revenue Share by Customer Base, %, 2005-2017
  • Table 104:API Market, Italy, Revenue Analysis by Product Types, $m, 2005-2017
  • Table 105:API Market, Italy, Revenue Share by Product Type, %, 2005-2017
  • Table 106:Synthetic Market, Italy, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 107:Synthetic Market, Italy, Revenue Share by Customer Base, %, 2005-2017
  • Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 109:Biotech Market, Italy, Revenue Share by Customer Base, %, 2005-2017
  • Table 110:API Market, The UK, Revenue Analysis by Product Types, $m, 2005-2017
  • Table 111:API Market, The UK, Revenue Share by Product Type, %, 2005-2017
  • Table 112:Synthetic Market, The UK, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 113:Synthetic Market, The UK, Revenue Share by Customer Base, %, 2005-2017
  • Table 114:Biotech Market, The UK, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 115:Biotech Market, The UK, Revenue Share by Customer Base, %, 2005-2017
  • Table 116:API Market, Spain, Revenue Analysis by Product Types, $m, 2005-2017
  • Table 117:API Market, Spain, Revenue Share by Product Type, %, 2005-2017
  • Table 118:Synthetic Market, Spain, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 119:Synthetic Market, Spain, Revenue Share by Customer Base, %, 2005-2017
  • Table 120:Biotech Market, Spain, Revenue Analysis by Customer Base, $m, 2005-2017
  • Table 121:Biotech Market, Spain, Revenue Share by Customer Base, %, 2005-2017

List of Figures

  • Figure 1: API Market, Global, Total Revenue Analysis ($m), 2005-2017
  • Figure 2: API Market, Global, Revenue Share by Product Type (%), 2011
  • Figure 3: Synthetic Market, Global, Revenue Analysis ($m), 2005-2017
  • Figure 4: Synthetic Market, Global, Revenue Share Analysis (%), 2011
  • Figure 5: Synthetic Market, Global, Revenue Share Analysis by Region (%), 2005-2017
  • Figure 6: Synthetic Market, Global, Revenue Share by Customer Base (%), 2011
  • Figure 7: Synthetic Market, Global, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 8: Biotech Market, Global, Revenue Analysis ($m), 2005-2017
  • Figure 9: Biotech Market, Global, Revenue Share by Region (%), 2011
  • Figure 10: Biotech Market, Global, Revenue Share Analysis by Region (%), 2005-2017
  • Figure 11: Biotech Market, Global, Revenue Share Analysis by Customer Base (%), 2011
  • Figure 12: Biotech Market, Global, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 13: CMO Market, Global, Process for Selection of CMO and Management of Outsourcing Project
  • Figure 14: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011
  • Figure 15: CMO Market Key Benefits of Outsourcing to CMOs
  • Figure 16: CMO Market, Global, Market Revenue ($m), 2005-2017
  • Figure 17: API Market, North America, Revenue Analysis by Product Type ($m), 2005-2017
  • Figure 18: API Market, North America, Revenue Share by Product Type (%), 2005-2017
  • Figure 19: Synthetic Market, North America, Revenue Analysis ($m), 2005-2017
  • Figure 20: Synthetic Market, North America, Revenue Share Analysis by Countries (%), 2011
  • Figure 21: Synthetic Market, North America, Performance and Potential Analysis Grid (%), 2005-2017
  • Figure 22: Synthetic Market, North America, Revenue Share Trend Analysis by Countries (%), 2005-2017
  • Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011
  • Figure 24: Synthetic Market, North America, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 25: Biotech Market, North America, Revenue Analysis ($m and %), 2005-2017
  • Figure 26: Biotech Market, North America, Revenue Share by Countries (%), 2011
  • Figure 27: Biotech Market, North America, Performance and Potential Analysis Grid (%), 2005-2017
  • Figure 28: Biotech Market, North America, Revenue Share Trend (%), 2005-2017
  • Figure 29: Biotech Market, North America, Revenue Share Analysis by Customer Base (%), 2011
  • Figure 30: Biotech Market, North America, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 31: API Market, North America, Revenue Split by Therapeutic Applications (%), 2011-2017
  • Figure 32: API Market, The US, Revenue Analysis by Product Type ($m), 2005-2017
  • Figure 33: API Market, The US, Revenue Share Analysis by Product Type (%), 2005-2017
  • Figure 34: Synthetic Market, The US, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 35: Synthetic Market, The US, Revenue Share by Customer Base (%), 2005-2017
  • Figure 36: Biotech API, The US, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 37: Biotech Market, The US, Revenue Share by Customer Base (%), 2005-2017
  • Figure 38: API Market, Canada, Revenue Analysis by Product Type ($m), 2005-2017
  • Figure 39: API Market, Canada, Revenue Share by Product Type (%), 2005-2017
  • Figure 40: Synthetic Market, Canada, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 41: Synthetic Market, Canada, Revenue Share by Customer Base (%), 2005-2017
  • Figure 42: Biotech Market, Canada, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 43: Biotech Market, Canada, Revenue Share by Customer Base (%), 2005-2017
  • Figure 44: API Market, Asia-Pacific, Market Revenues ($m), 2005-2017
  • Figure 45: API Market, Asia-Pacific, Revenue Share by Product Type (%), 2011
  • Figure 46: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005-2017
  • Figure 47: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
  • Figure 48: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005-2017
  • Figure 49: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005-2017
  • Figure 50: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011
  • Figure 51: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Type ($m), 2005-2017
  • Figure 52: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005-2017
  • Figure 53: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
  • Figure 54: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005-2017
  • Figure 55: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005-2017
  • Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011
  • Figure 57: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005-2017
  • Figure 58: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011-2017
  • Figure 59: API Market, Japan, Market Revenues by Product Type ($m), 2005-2017
  • Figure 60: API Market, Japan, Revenue Share Analysis by Product Types (%), 2005-2017
  • Figure 61: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 62: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005-2017
  • Figure 63: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 64: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005-2017
  • Figure 65: API Market, China, Market Revenues by Product Type ($m), 2005-2017
  • Figure 66: API Market, China, Revenue Share Analysis by Product Type (%), 2005-2017
  • Figure 67: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 68: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017
  • Figure 69: Biotech Market, China, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 70: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017
  • Figure 71: API Market, South Korea, Market Revenues by Product Type ($m), 2005-2017
  • Figure 72: API Market, South Korea, Revenue Share Analysis by Product Types (%), 2005-2017
  • Figure 73: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 74: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005-2017
  • Figure 75: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 76: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005-2017
  • Figure 77: API Market, India, Market Revenues by Product Types ($m), 2005-2017
  • Figure 78: API Market, India, Revenue Share Analysis by Product Types (%), 2005-2017
  • Figure 79: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 80: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005-2017
  • Figure 81: Biotech Market, India, Market Revenues by Customer Base ($m), 2005-2017
  • Figure 82: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005-2017
  • Figure 83: API Market, Europe, Total Revenue Analysis ($m), 2005-2017
  • Figure 84: API Market, Europe, Revenue Share by Product Types (%), 2011
  • Figure 85: Synthetic Market, Europe, Revenue Analysis ($m), 2005-2017
  • Figure 86: Synthetic Market, Europe, Revenue Share Analysis by Countries (%), 2011
  • Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005-2017
  • Figure 88: Synthetic Market, Europe, Revenue Share Trend Analysis by Countries (%), 2005-2017
  • Figure 89: Synthetic Market, Europe, Revenue Share by Customer Base, (%), 2011
  • Figure 90: Synthetic Market, Europe, Revenue Trend by Product Types ($m), 2005-2017
  • Figure 91: Biotech Market, Europe, Revenue Analysis ($m and %), 2005-2017
  • Figure 92: Biotech Market, Europe, Revenue Share by Countries (%), 2011
  • Figure 93: Biotech Market, Europe, Performance and Potential Analysis Grid (%), 2005-2017
  • Figure 94: Biotech Market, Europe, Revenue Share Trend (%), 2005-2017
  • Figure 95: Biotech Market, Europe, Revenue Share Analysis by Customer Base (%), 2011
  • Figure 96: Biotech Market, Europe, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 97: API Market, Europe, Revenue Split by Therapeutic Applications (%), 2011-2017
  • Figure 98: API Market, Germany, Revenue Analysis by Product Types ($m), 2005-2017
  • Figure 99: API Market, Germany, Revenue Share by Product Type (%), 2005-2017
  • Figure 100: Synthetic Market, Germany, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 101: Synthetic Market, Germany, Revenue Share by Customer Base (%), 2005-2017
  • Figure 102: Biotech Market, Germany, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 103: Biotech Market, Germany, Revenue Share by Customer Base (%), 2005-2017
  • Figure 104: API Market, France, Revenue Analysis by Product Types ($m), 2005-2017
  • Figure 105: API Market, France, Revenue Share by Product Type (%), 2005-2017
  • Figure 106: Synthetic Market, France, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 107: Synthetic Market, France, Revenue Share by Customer Base (%), 2005-2017
  • Figure 108: Biotech Market, France, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 109: Biotech Market, France, Revenue Share by Customer Base (%), 2005-2017
  • Figure 110: API Market, Italy, Revenue Analysis by Product Types ($m), 2005-2017
  • Figure 111: API Market, Italy, Revenue Share by Product Type (%), 2005-2017
  • Figure 112: Synthetic Market, Italy, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 113: Synthetic Market, Italy, Revenue Share by Customer Base (%), 2005-2017
  • Figure 114: Biotech Market, Italy, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 115: Biotech Market, Italy, Revenue Share by Customer Base (%), 2005-2017
  • Figure 116: API Market, The UK, Revenue Analysis by Product Types ($m), 2005-2017
  • Figure 117: API Market, The UK, Revenue Share by Product Type (%), 2005-2017
  • Figure 118: Synthetic Market, The UK, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 119: Synthetic Market, The UK, Revenue Share by Customer Base (%), 2005-2017
  • Figure 120: Biotech Market, The UK, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 121: Biotech Market, The UK, Revenue Share by Customer Base (%), 2005-2017
  • Figure 122: API Market, Spain, Revenue Analysis by Product Types ($m), 2005-2017
  • Figure 123: API Market, Spain, Revenue Share by Product Type (%), 2005-2017
  • Figure 124: Synthetic Market, Spain, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005-2017
  • Figure 126: Biotech Market, Spain, Revenue Analysis by Customer Base ($m), 2005-2017
  • Figure 127: Biotech Market, Spain, Revenue Share by Customer Base (%), 2005-2017
Back to Top